NetTargets Inc.
16 Jun 2025
https://www.sedaily.com/NewsView/2GU3YG46R3
https://www.yakup.com/news/index.html?mode=view&cat=12&nid=311888
The collaboration combines NetTargets' proprietary explainable AI drug discovery platform—to identify synergistic drug pairings—with Debiopharm’s MultiLINK™ ADC Technology for coordinated delivery of two distinct warheads on a single ADC.
NetTargets has been selected as one of the top 10 semifinalists among hundreds of drug discovery startups worldwide. The AI Discovery Award is an annual recognition by Nebius AI, a European AI-centric public cloud provider with global reach.